GHIGO, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 5.487
EU - Europa 3.794
AS - Asia 1.600
SA - Sud America 56
AF - Africa 51
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 5
Totale 11.032
Nazione #
US - Stati Uniti d'America 5.407
DK - Danimarca 1.338
CN - Cina 1.047
IT - Italia 737
IE - Irlanda 350
DE - Germania 290
SE - Svezia 238
FR - Francia 174
SG - Singapore 169
UA - Ucraina 119
FI - Finlandia 87
GB - Regno Unito 85
JP - Giappone 82
AT - Austria 78
KR - Corea 73
CA - Canada 71
BE - Belgio 69
PT - Portogallo 60
PL - Polonia 58
IN - India 56
BR - Brasile 51
VN - Vietnam 45
HK - Hong Kong 41
AU - Australia 38
CH - Svizzera 38
TW - Taiwan 24
IR - Iran 21
ES - Italia 16
NL - Olanda 16
SN - Senegal 15
ET - Etiopia 10
NG - Nigeria 10
RU - Federazione Russa 10
NO - Norvegia 8
TH - Thailandia 8
CZ - Repubblica Ceca 6
IL - Israele 6
TR - Turchia 6
EU - Europa 5
MX - Messico 5
ZA - Sudafrica 5
BD - Bangladesh 4
SI - Slovenia 4
AR - Argentina 3
GR - Grecia 3
HU - Ungheria 3
ID - Indonesia 3
MY - Malesia 3
PK - Pakistan 3
BW - Botswana 2
BY - Bielorussia 2
BZ - Belize 2
EG - Egitto 2
MO - Macao, regione amministrativa speciale della Cina 2
MU - Mauritius 2
NP - Nepal 2
RO - Romania 2
UG - Uganda 2
UY - Uruguay 2
CR - Costa Rica 1
CY - Cipro 1
GH - Ghana 1
GP - Guadalupe 1
IQ - Iraq 1
IS - Islanda 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MK - Macedonia 1
NE - Niger 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PS - Palestinian Territory 1
ZM - Zambia 1
Totale 11.032
Città #
Ann Arbor 1.594
Chandler 676
Dublin 349
Beijing 274
Ashburn 264
Torino 255
Houston 244
Shenyang 216
Wilmington 211
Fairfield 159
Nyköping 137
Singapore 119
Dearborn 112
Villeurbanne 93
Medford 86
Princeton 86
Vienna 76
Jacksonville 74
Boston 68
Seattle 68
Turin 67
Munich 62
Redwood City 60
Woodbridge 52
Guangzhou 49
Hangzhou 46
Milan 46
Warsaw 41
Cambridge 35
Pisa 32
Fremont 29
Grafing 29
Montréal 29
Chennai 27
Nanjing 27
Shanghai 26
Palaiseau 25
Asti 23
Brussels 23
Seoul 23
Fortaleza 22
Santa Clara 22
Buffalo 21
Los Angeles 21
Dong Ket 20
Chengdu 19
Maasmechelen 19
Tokyo 19
Rome 18
Boardman 16
Hebei 16
Verona 16
Baltimore 15
Falls Church 15
New York 14
San Diego 14
Taipei 14
Evanston 13
Hong Kong 13
Wuhan 13
Atlanta 12
Castellana Grotte 12
Copenhagen 12
Pittsburgh 12
Brisbane 11
Campinas 11
Hefei 11
Chicago 10
Norwalk 10
Berlin 9
Bornem 9
Guiyang 9
Kunming 9
Kyoto 9
Sydney 9
Toronto 9
Heidelberg 8
Hyderabad 8
Lappeenranta 8
London 8
Ottawa 8
Phoenix 8
Trieste 8
Washington 8
Xian 8
Abuja 7
Bonn 7
Central 7
Columbus 7
Des Moines 7
Helsinki 7
Jinan 7
Naples 7
Paris 7
Regensburg 7
Tehran 7
Zhengzhou 7
Zurich 7
Acton 6
Addis Ababa 6
Totale 6.591
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 598
Phosphoinositide 3-Kinase Gamma Inhibition Protects from Anthracycline Cardiotoxicity and Reduces Tumor Growth 559
Hemopexin Therapy Improves Cardiovascular Function by Preventing Heme-Induced Endothelial Toxicity in Mouse Models of Hemolytic Diseases 512
Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress 492
Metabolic Alterations in a Slow-Paced Model of Pancreatic Cancer-Induced Wasting 320
Distinct Effects of Leukocyte and Cardiac Phosphoinositide 3-Kinase {gamma} Activity in Pressure Overload-Induced Cardiac Failure 283
Pulmonary-derived phosphoinositide 3-kinase gamma (PI3Kγ) contributes to ventilator-induced lung injury and edema. 241
Contractile Function during Angiotensin-II Activation: Increased Nox2 Activity Modulates Cardiac Calcium Handling via Phospholamban Phosphorylation 238
Integrating Cardiac PIP(3) and cAMP Signaling through a PKA Anchoring Function of p110γ. 234
Crossroads of PI3K and Rac pathways 223
Myocyte signalling in leucocyte recruitment to the heart. 222
Identification of the macromolecular complex responsible for PI3Kgamma-dependent regulation of cAMP levels. 220
Lack of kinase-independent activity of PI3Kγ in locus coeruleus induces ADHD symptoms through increased CREB signaling 217
Therapeutic applications of PI3K inhibitors in cardiovascular diseases. 217
Anchoring proteins as regulators of signaling pathways. 215
PI3K in cancer-stroma interactions: bad in seed and ugly in soil. 213
Phosphoinositide 3-kinase γ protects against catecholamine-induced ventricular arrhythmia through protein kinase A-mediated regulation of distinct phosphodiesterases. 208
Ablation of Calcineurin Aβ Reveals Hyperlipidemia and Signaling Cross-talks with Phosphodiesterases. 207
Dietary ω-3 fatty acids protect against vasculopathy in a transgenic mouse model of sickle cell disease 206
Specific PI3K Isoform Modulation in Heart Failure: Lessons from Transgenic Mice. 202
Different inhibition of Gβγ-stimulated class IB phosphoinositide 3-kinase (PI3K) variants by a monoclonal antibody. Specific function of p101 as a Gβγ-dependent regulator of PI3Kγ enzymatic activity 198
NADPH Oxidases in Heart Failure: Poachers or Gamekeepers? 198
PI3K inhibition in inflammation:Toward tailored therapies for specific diseases 193
Taming the PI3K team to hold inflammation and cancer at bay 192
Disruption of ArhGAP15 results in hyperactive Rac1, affects the architecture and function of hippocampal inhibitory neurons and causes cognitive deficits 191
Phosphoinositide 3-kinases in health and disease. 189
null 186
Hyper-activation of the Rho-GTPase Rac1 via disruption of ArhGAP15 results in reduced architectural and functional complexity 184
Elastin degradation and ensuing inflammation as emerging keys to atherosclerosis. 183
Phosphoinositides and cardiovascular diseases. 182
Isoform Selective Phosphoinositide 3-Kinase gamma and delta Inhibitors and Their Therapeutic Potential 176
Hyperactivity of Rac1-GTPase pathway impairs neuritogenesis of cortical neurons by altering actin dynamics 173
Metabolic Aspects of Anthracycline Cardiotoxicity 149
Data demonstrating the anti-oxidant role of hemopexin in the heart 142
Antineoplastic drug-induced cardiotoxicity: A redox perspective 142
Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2α Scaffolding Function 134
Molecular mechanism of action of Pelargonidin-3-O-glucoside, the main anthocyanin responsible for the anti-inflammatory effect of strawberry fruits 127
Therapeutic Targeting of PDEs and PI3K in Heart Failure with Preserved Ejection Fraction (HFpEF) 121
A PI3Kγ mimetic peptide triggers CFTR gating, bronchodilation, and reduced inflammation in obstructive airway diseases 105
Dysfunctional inflammation in cystic fibrosis airways: From mechanisms to novel therapeutic approaches 84
Rac signal adaptation controls neutrophil mobilization from the bone marrow 73
Liver-Specific siRNA-Mediated Stat3 or C3 Knockdown Improves the Outcome of Experimental Autoimmune Myocarditis 72
The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity 71
Pi3k signaling in chronic obstructive pulmonary disease: Mechanisms, targets, and therapy 70
Tregs restrain dendritic cell autophagy to ameliorate autoimmunity 70
New signal transduction paradigms in anthracycline-induced cardiotoxicity 66
Data demonstrating the role of peroxiredoxin 2 as important anti-oxidant system in lung homeostasis 65
Phosphoinositide 3-kinase: friend and foe in cardiovascular disease 62
Models of Heart Failure Based on the Cardiotoxicity of Anticancer Drugs 62
Potential therapeutic applications of AKAP disrupting peptides 61
A novel protective role for activating transcription factor 3 in the cardiac response to metabolic stress 59
PI3K and Calcium Signaling in Cardiovascular Disease 59
PI3Ks in Diabetic Cardiomyopathy 58
Peroxiredoxin-2 plays a pivotal role as multimodal cytoprotector in the early phase of pulmonary hypertension 57
Toward standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial Function 57
Cardiac Overexpression of PDE4B Blunts β-Adrenergic Response and Maladaptive Remodeling in Heart Failure 57
Mechanisms underlying the cross-talk between heart and cancer 56
Cancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications 54
PI(3,4)P2-mediated cytokinetic abscission prevents early senescence and cataract formation 54
Therapeutic peptides for the treatment of cystic fibrosis: Challenges and perspectives 50
Inhaled Biologicals for the Treatment of Cystic Fibrosis 49
Signaling pathways underlying anthracycline cardiotoxicity 49
Autophagy and cancer therapy cardiotoxicity: From molecular mechanisms to therapeutic opportunities 49
Preventing and Treating Anthracycline Cardiotoxicity: New Insights 49
An integrated approach to cardioprotection in lymphomas 45
Cell-specific roles of p110β in myocardial ischemia 44
cAMP/PKA signaling compartmentalization in cardiomyocytes: Lessons from FRET-based biosensors 44
Cardiac dysfunction in cancer patients: Beyond direct cardiomyocyte damage of anticancer drugs: Novel cardio-oncology insights from the joint 2019 meeting of the ESC working groups of myocardial function and cellular biology of the heart 44
Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer? 43
Cell signaling and regulation of CFTR expression in cystic fibrosis cells in the era of high efficiency modulator therapy 42
The Interplay Between Autophagy and Senescence in Anthracycline Cardiotoxicity 41
The human fetal and adult stem cell secretome can exert cardioprotective paracrine effects against cardiotoxicity and oxidative stress from cancer treatment 41
Response by Vandecasteele et al to Letter Regarding Article, âCardiac Overexpression of PDE4B Blunts Î-Adrenergic Response and Maladaptive Remodeling in Heart Failureâ 39
Leukocyte and cardiac phosphoinositide 3-kinase γ activity in pressure overload-induced cardiac failure. 38
New avenues in cardio-oncology 38
Oxidative stress in anticancer therapies-related cardiac dysfunction 33
Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexia 33
Role of Protein Kinase A-Mediated Phosphorylation in CFTR Channel Activity Regulation 33
'Circulating' RNA-based therapies in Cardio-Oncology 32
A non-catalytic function of PI3Kγ drives smooth muscle cell proliferation after arterial damage 31
Roles of phosphatidyl inositol 3 kinase gamma (PI3Kγ) in respiratory diseases 30
Preclinical Models of Cancer Therapy-Associated Cardiovascular Toxicity: A Scientific Statement From the American Heart Association 30
Combined inhibition of PI3Kβ and PI3Kγ reduces fat mass by enhancing α-MSH-dependent sympathetic drive. 29
Neurotoxic Effect of Doxorubicin Treatment on Cardiac Sympathetic Neurons 23
Inhibition of aquaporin-1 prevents myocardial remodeling by blocking the transmembrane transport of hydrogen peroxide 23
Understanding the heart-brain axis response in COVID-19 patients: A suggestive perspective for therapeutic development 23
Duality of Nrf2 in iron-overload cardiomyopathy 22
Illuminating cAMP Dynamics at Ryanodine Receptors in Arrhythmias 21
Pi3k as mediator of apoptosis and contractile dysfunction in tgfβ1-stimulated cardiomyocytes 21
Young@Heart: empowering the next generation of cardiovascular researchers 20
Circulating hemopexin modulates anthracycline cardiac toxicity in patients and in mice 17
It Takes Two to Tango! Protein–Protein Interactions behind cAMP-Mediated CFTR Regulation 16
In Humanized Sickle Cell Mice, Imatinib Protects Against Sickle Cell-Related Injury 14
p53 at the Intersection of Cardiac Fibroblast Proliferation and Activation: Answers and Questions 14
MST1 mediates doxorubicin-induced cardiomyopathy by SIRT3 downregulation 12
Gene therapy with phosphodiesterases 2A and 4B ameliorates heart failure and arrhythmias by improving subcellular cAMP compartmentation 11
Editorial: Cardio-oncology and reverse cardio-oncology: the manifold interconnections between heart failure and cancer 9
Priorities in Cardio-Oncology Basic and Translational Science: GCOS 2023 Symposium Proceedings: JACC: CardioOncology State-of-the-Art Review 8
Emerging Roles of Phospholipase C Beta Isozymes as Potential Biomarkers in Cardiac Disorders 7
Totale 11.476
Categoria #
all - tutte 29.246
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.246


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.159 0 0 131 124 179 306 273 209 217 242 232 246
2020/2021949 73 40 30 23 75 43 116 25 139 81 58 246
2021/20222.361 236 231 197 243 192 191 176 172 143 103 240 237
2022/20232.161 184 183 75 203 176 474 145 135 252 69 123 142
2023/20241.265 157 170 126 86 94 94 87 92 26 135 69 129
2024/2025486 78 408 0 0 0 0 0 0 0 0 0 0
Totale 11.476